{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:22:31Z","timestamp":1783981351201,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10375-9","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:24:28Z","timestamp":1740684268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Deciphering the anticancer potential of thymoquinone: in-depth exploration of the potent flavonoid from Nigella sativa"],"prefix":"10.1007","volume":"52","author":[{"given":"Bunty","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anidrisha","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep Singh","family":"Tuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjawal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"10375_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/foods10040839","volume":"10","author":"M Samtiya","year":"2021","unstructured":"Samtiya M, Aluko RE, Dhewa T, Moreno-Rojas JM (2021) Potential health benefits of plant food-derived bioactive components: an overview. Foods 10:839","journal-title":"Foods"},{"key":"10375_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35278","author":"AM Filho","year":"2024","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F (2024) The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.35278","journal-title":"Int J Cancer"},{"key":"10375_CR3","first-page":"423","volume":"3","author":"K Sak","year":"2022","unstructured":"Sak K (2022) Anticancer action of plant products: changing stereotyped attitudes. Explor Target Antitumor Ther 3:423\u2013427","journal-title":"Explor Target Antitumor Ther"},{"issue":"6","key":"10375_CR4","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3390\/nu13061784","volume":"13","author":"MA Hannan","year":"2021","unstructured":"Hannan MA, Rahman MA, Sohag AAM, Uddin MJ, Dash R, Sikder MH, Rahman MS, Timalsina B, Munni YA, Sarker PP, Alam M, Mohibbullah M, Haque MN, Jahan I, Hossain MT, Afrin T, Rahman MM, Tahjib-Ul-Arif M, Mitra S, Oktaviani DF, Khan MK, Choi HJ, Moon IS, Kim B (2021) Black cumin (Nigella sativa L.): a comprehensive review on phytochemistry, health benefits, molecular pharmacology, and safety. Nutrients 13(6):1784. https:\/\/doi.org\/10.3390\/nu13061784","journal-title":"Nutrients"},{"issue":"1","key":"10375_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/cimb46010010","volume":"46","author":"N Kurowska","year":"2023","unstructured":"Kurowska N, Madej M, Strzalka-Mrozik B (2023) Thymoquinone: a promising therapeutic agent for the treatment of colorectal cancer. Curr Issues Mol Biol 46(1):121\u2013139. https:\/\/doi.org\/10.3390\/cimb46010010","journal-title":"Curr Issues Mol Biol"},{"key":"10375_CR6","unstructured":"National Center for Biotechnology Information (2023) PubChem Compound Summary for CID 10281, Thymoquinone. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Thymoquinone. Accessed 22 Oct 2023"},{"issue":"8","key":"10375_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jsps.2019.09.008","volume":"27","author":"A Ahmad","year":"2019","unstructured":"Ahmad A, Mishra RK, Vyawahare A, Kumar A, Rehman MU, Qamar W, Khan AQ, Khan R (2019) Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive\/anticancer agent: chemistry and biological effects. Saudi Pharm J 27(8):1113\u20131126. https:\/\/doi.org\/10.1016\/j.jsps.2019.09.008","journal-title":"Saudi Pharm J"},{"key":"10375_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3389\/fphar.2017.00656","volume":"8","author":"SN Goyal","year":"2017","unstructured":"Goyal SN, Prajapati CP, Gore PR, Patil CR, Mahajan UB, Sharma C, Talla SP, Ojha SK (2017) Therapeutic potential and pharmaceutical development of thymoquinone: a multitargeted molecule of natural origin. Front Pharmacol 8:656. https:\/\/doi.org\/10.3389\/fphar.2017.00656","journal-title":"Front Pharmacol"},{"issue":"21","key":"10375_CR9","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.3390\/molecules25214873","volume":"25","author":"M Ghosh","year":"2020","unstructured":"Ghosh M, Schepetkin IA, \u00d6zek G, \u00d6zek T, Khlebnikov AI, Damron DS, Quinn MT (2020) Essential oils from Monarda fistulosa: chemical composition and activation of transient receptor potential A1 (TRPA1) channels. Molecules 25(21):4873. https:\/\/doi.org\/10.3390\/molecules25214873","journal-title":"Molecules"},{"issue":"12","key":"10375_CR10","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1089\/ars.2009.2541","volume":"11","author":"GT Wondrak","year":"2009","unstructured":"Wondrak GT (2009) Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11(12):3013\u20133069. https:\/\/doi.org\/10.1089\/ars.2009.2541","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10375_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37(1):266. https:\/\/doi.org\/10.1186\/s13046-018-0909-x","journal-title":"J Exp Clin Cancer Res"},{"key":"10375_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/antiox12030607","volume":"12","author":"R Sakib","year":"2023","unstructured":"Sakib R, Caruso F, Aktar S, Belli S, Kaur S, Hernandez M, Rossi M (2023) Antioxidant properties of thymoquinone, thymohydroquinone and black cumin (Nigella sativa L.) seed oil: scavenging of superoxide radical studied using cyclic voltammetry, DFT and single crystal X-ray diffraction. Antioxidants 12:607. https:\/\/doi.org\/10.3390\/antiox12030607","journal-title":"Antioxidants"},{"issue":"6","key":"10375_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s11095-010-0145-3","volume":"27","author":"S Banerjee","year":"2010","unstructured":"Banerjee S, Azmi AS, Padhye S, Singh MW, Baruah JB, Philip PA, Sarkar FH, Mohammad RM (2010) Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. Pharm Res 27(6):1146\u20131158. https:\/\/doi.org\/10.1007\/s11095-010-0145-3","journal-title":"Pharm Res"},{"key":"10375_CR14","doi-asserted-by":"publisher","first-page":"111492","DOI":"10.1016\/j.biopha.2021.111492","volume":"138","author":"Z Kohandel","year":"2021","unstructured":"Kohandel Z, Farkhondeh T, Aschner M, Samarghandian S (2021) Anti-inflammatory effects of thymoquinone and its protective effects against several diseases. Biomed Pharmacother 138:111492. https:\/\/doi.org\/10.1016\/j.biopha.2021.111492","journal-title":"Biomed Pharmacother"},{"key":"10375_CR15","doi-asserted-by":"crossref","unstructured":"Jain A, Dhruw L, Sinha P, Pradhan A, Sharma R, Gupta B (2021) Chapter 52 \u2013 Thymoquinone. In: Gupta RC, Lall R, Srivastava A (ed) Nutraceuticals (Second Edition). Academic Press, pp 891\u2013901, ISBN 9780128210383","DOI":"10.1016\/B978-0-12-821038-3.00052-5"},{"issue":"7","key":"10375_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.5306\/wjco.v12.i7.522","volume":"12","author":"Z Fatfat","year":"2021","unstructured":"Fatfat Z, Fatfat M, Gali-Muhtasib H (2021) Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells. World J Clin Oncol 12(7):522\u2013543. https:\/\/doi.org\/10.5306\/wjco.v12.i7.522","journal-title":"World J Clin Oncol"},{"key":"10375_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/antiox9121260","volume":"9","author":"M Mekhemar","year":"2020","unstructured":"Mekhemar M, Hassan Y, D\u00f6rfer C (2020) Nigella sativa and thymoquinone: a natural blessing for periodontal therapy. Antioxidants 9:1260. https:\/\/doi.org\/10.3390\/antiox9121260","journal-title":"Antioxidants"},{"key":"10375_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13318-014-0207-8","volume":"40","author":"KM Alkharfy","year":"2015","unstructured":"Alkharfy KM, Ahmad A, Khan RMA, Al-Shagha WM (2015) Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model. Eur J Drug Metab Pharmacokinet 40:319\u2013323","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"10375_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jsps.2020.01.022","volume":"28","author":"A Ahmad","year":"2020","unstructured":"Ahmad A, Alqahtani S, Jan BL, Raish M, Rabba AK, Alkharfy KM (2020) Gender effect on the pharmacokinetics of thymoquinone: preclinical investigation and in silico modeling in male and female rats. Saudi Pharm J 28(4):403\u2013408. https:\/\/doi.org\/10.1016\/j.jsps.2020.01.022","journal-title":"Saudi Pharm J"},{"issue":"18","key":"10375_CR20","doi-asserted-by":"publisher","first-page":"10246","DOI":"10.3390\/ijms231810246","volume":"23","author":"Y Liu","year":"2022","unstructured":"Liu Y, Huang L, Kim MY, Cho JY (2022) The role of thymoquinone in inflammatory response in chronic diseases. Int J Mol Sci 23(18):10246. https:\/\/doi.org\/10.3390\/ijms231810246","journal-title":"Int J Mol Sci"},{"key":"10375_CR21","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.2147\/IJN.S262395","volume":"15","author":"FH Zakarial Ansar","year":"2020","unstructured":"Zakarial Ansar FH, Latifah SY, Wan Kamal WHB, Khong KC, Ng Y, Foong JN, Gopalsamy B, Ng WK, How CW, Ong YS, Abdullah R, Aziz MY (2020) Pharmacokinetics and biodistribution of thymoquinone-loaded nanostructured lipid carrier after oral and intravenous administration into rats. Int J Nanomedicine 15:7703\u20137717. https:\/\/doi.org\/10.2147\/IJN.S262395","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10375_CR22","doi-asserted-by":"publisher","first-page":"10421","DOI":"10.1002\/jcp.27710","volume":"234","author":"S Samarghandian","year":"2019","unstructured":"Samarghandian S, Azimi-Nezhad M, Farkhondeh T (2019) Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells. J Cell Physiol 234(7):10421\u201310431. https:\/\/doi.org\/10.1002\/jcp.27710","journal-title":"J Cell Physiol"},{"issue":"6","key":"10375_CR23","first-page":"97","volume":"62","author":"MM Taha","year":"2016","unstructured":"Taha MM, Sheikh BY, Salim LZ, Mohan S, Khan A, Kamalidehghan B, Ahmadipour F, Abdelwahab SI (2016) Thymoquinone induces apoptosis and increase ROS in ovarian cancer cell line. Cell Mol Biol (Noisy-le-grand) 62(6):97\u2013101","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"23","key":"10375_CR24","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.3390\/ijms232314669","volume":"23","author":"RJ Abdualmjid","year":"2022","unstructured":"Abdualmjid RJ, Sergi CM (2022) Mitochondrial dysfunction and induction of apoptosis in hepatocellular carcinoma and cholangiocarcinoma cell lines by thymoquinone. Int J Mol Sci 23(23):14669. https:\/\/doi.org\/10.3390\/ijms232314669","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10375_CR25","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/ptr.7820","volume":"37","author":"P He","year":"2023","unstructured":"He P, He Y, Ma J, Liu Y, Liu C, Baoping Y, Dong W (2023) Thymoquinone induces apoptosis and protective autophagy in gastric cancer cells by inhibiting the PI3K\/Akt\/mTOR pathway. Phytother Res 37(8):3467\u20133480. https:\/\/doi.org\/10.1002\/ptr.7820","journal-title":"Phytother Res"},{"key":"10375_CR26","doi-asserted-by":"publisher","first-page":"821344","DOI":"10.3389\/fphar.2022.821344","volume":"13","author":"B Rah","year":"2022","unstructured":"Rah B, Rather RA, Bhat GR, Baba AB, Mushtaq I, Farooq M, Yousuf T, Dar SB, Parveen S, Hassan R, Mohammad F, Qassim I, Bhat A, Ali S, Zargar MH, Afroze D (2022) JAK\/STAT signaling: molecular targets, therapeutic opportunities, and limitations of targeted inhibitions in solid malignancies. Front Pharmacol 13:821344. https:\/\/doi.org\/10.3389\/fphar.2022.821344","journal-title":"Front Pharmacol"},{"issue":"16","key":"10375_CR27","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3748\/wjg.v22.i16.4149","volume":"22","author":"WQ Zhu","year":"2016","unstructured":"Zhu WQ, Wang J, Guo XF, Liu Z, Dong WG (2016) Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. World J Gastroenterol 22(16):4149\u20134159. https:\/\/doi.org\/10.3748\/wjg.v22.i16.4149","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10375_CR28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/ph14040369","volume":"14","author":"B Almajali","year":"2021","unstructured":"Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN (2021) Thymoquinone, as a novel therapeutic candidate of cancers. Pharmaceuticals (Basel) 14(4):369. https:\/\/doi.org\/10.3390\/ph14040369","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10375_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.31557\/APJCP.2021.22.3.879","volume":"22","author":"B Almajali","year":"2021","unstructured":"Almajali B, Al-Jamal HAN, Wan Taib WR, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN, Tajudin SA (2021) Thymoquinone suppresses cell proliferation and enhances apoptosis of HL60 leukemia cells through re-expression of JAK\/STAT negative regulators. Asian Pac J Cancer Prev 22(3):879\u2013885. https:\/\/doi.org\/10.31557\/APJCP.2021.22.3.879","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10375_CR30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/ph16060884","volume":"16","author":"FA Al-Rawashde","year":"2023","unstructured":"Al-Rawashde FA, Al-Sanabra OM, Alqaraleh M, Jaradat AQ, Al-Wajeeh AS, Johan MF, Wan Taib WR, Ismail I, Al-Jamal HAN (2023) Thymoquinone enhances apoptosis of K562 chronic myeloid leukemia cells through hypomethylation of SHP-1 and inhibition of JAK\/STAT signaling pathway. Pharmaceuticals (Basel) 16(6):884. https:\/\/doi.org\/10.3390\/ph16060884","journal-title":"Pharmaceuticals (Basel)"},{"issue":"31","key":"10375_CR31","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.18632\/oncotarget.27426","volume":"11","author":"F Ballout","year":"2020","unstructured":"Ballout F, Monzer A, Fatfat M, Ouweini HE, Jaffa MA, Abdel-Samad R, Darwiche N, Abou-Kheir W, Gali-Muhtasib H (2020) Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem\/progenitor cells. Oncotarget 11(31):2959\u20132972. https:\/\/doi.org\/10.18632\/oncotarget.27426","journal-title":"Oncotarget"},{"issue":"12","key":"10375_CR32","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.31557\/APJCP.2021.22.12.3959","volume":"22","author":"FA Al-Rawashde","year":"2021","unstructured":"Al-Rawashde FA, Wan Taib WR, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN (2021) Thymoquinone induces downregulation of BCR-ABL\/JAK\/STAT pathway and apoptosis in K562 leukemia cells. Asian Pac J Cancer Prev 22(12):3959\u20133965. https:\/\/doi.org\/10.31557\/APJCP.2021.22.12.3959","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10375_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","volume":"8","author":"ZL Liu","year":"2023","unstructured":"Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L (2023) Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 8(1):198. https:\/\/doi.org\/10.1038\/s41392-023-01460-1","journal-title":"Signal Transduct Target Ther"},{"issue":"18","key":"10375_CR34","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.3390\/ijms231810962","volume":"23","author":"D La Mendola","year":"2022","unstructured":"La Mendola D, Trincavelli ML, Martini C (2022) Angiogenesis in disease. Int J Mol Sci 23(18):10962. https:\/\/doi.org\/10.3390\/ijms231810962","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10375_CR35","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/ijms22073765","volume":"22","author":"F Lopes-Coelho","year":"2021","unstructured":"Lopes-Coelho F, Martins F, Pereira SA, Serpa J (2021) Anti-angiogenic therapy: current challenges and future perspectives. Int J Mol Sci 22(7):3765. https:\/\/doi.org\/10.3390\/ijms22073765","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10375_CR36","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77(9):1745\u20131770. https:\/\/doi.org\/10.1007\/s00018-019-03351-7","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10375_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4143\/crt.2016.176","volume":"49","author":"LT Chen","year":"2017","unstructured":"Chen LT, Oh DY, Ryu MH, Yeh KH, Yeo W, Carlesi R, Cheng R, Kim J, Orlando M, Kang YK (2017) Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: a systematic review. Cancer Res Treat 49(4):851\u2013868. https:\/\/doi.org\/10.4143\/crt.2016.176","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10375_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3747\/co.v13i1.77","volume":"13","author":"SM Sagar","year":"2006","unstructured":"Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 13(1):14\u201326","journal-title":"Curr Oncol"},{"issue":"3","key":"10375_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bionut.2012.03.011","volume":"2","author":"A Paramasivam","year":"2012","unstructured":"Paramasivam A, Kalaimangai M, Sambantham S, Anandan B, Jayaraman G (2012) Anti-angiogenic activity of thymoquinone by the down-regulation of VEGF using zebrafish (Danio rerio) model. Biomed Prev Nutr 2(3):169\u2013173. https:\/\/doi.org\/10.1016\/j.bionut.2012.03.011","journal-title":"Biomed Prev Nutr"},{"issue":"7","key":"10375_CR40","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/1535-7163.MCT-08-0124","volume":"7","author":"T Yi","year":"2008","unstructured":"Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M (2008) Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 7(7):1789\u20131796. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0124","journal-title":"Mol Cancer Ther"},{"key":"10375_CR41","doi-asserted-by":"publisher","first-page":"15904","DOI":"10.3390\/ijms232415904","volume":"23","author":"SA Tadros","year":"2022","unstructured":"Tadros SA, Attia YM, Maurice NW, Fahim SA, Abdelwahed FM, Ibrahim S, Badary OA (2022) Thymoquinone suppresses angiogenesis in DEN-induced hepatocellular carcinoma by targeting miR-1-3p. Int J Mol Sci 23:15904. https:\/\/doi.org\/10.3390\/ijms232415904","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10375_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/or.2012.2165","volume":"29","author":"L Peng","year":"2013","unstructured":"Peng L, Liu A, Shen Y, Xu HZ, Yang SZ, Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, Cheng SW, Shen WD (2013) Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-\u03baB pathway. Oncol Rep 29(2):571\u2013578. https:\/\/doi.org\/10.3892\/or.2012.2165","journal-title":"Oncol Rep"},{"issue":"1","key":"10375_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12906-021-03246-w","volume":"21","author":"S Haiaty","year":"2021","unstructured":"Haiaty S, Rashidi MR, Akbarzadeh M, Bazmani A, Mostafazadeh M, Nikanfar S, Zibaei Z, Rahbarghazi R, Nouri M (2021) Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells. BMC Complement Med Ther 21(1):83. https:\/\/doi.org\/10.1186\/s12906-021-03246-w. (Erratum in: BMC Complement Med Ther. 2021;21(1):266)","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"10375_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5(1):28. https:\/\/doi.org\/10.1038\/s41392-020-0134-x","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10375_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2174\/092986711794927711","volume":"18","author":"YL Jiang","year":"2011","unstructured":"Jiang YL, Liu ZP (2011) Natural products as anti-invasive and anti-metastatic agents. Curr Med Chem 18(6):808\u2013829. https:\/\/doi.org\/10.2174\/092986711794927711","journal-title":"Curr Med Chem"},{"issue":"1","key":"10375_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2011.10.001","volume":"1825","author":"B Bauvois","year":"2012","unstructured":"Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. BiochimBiophys Acta 1825(1):29\u201336. https:\/\/doi.org\/10.1016\/j.bbcan.2011.10.001","journal-title":"BiochimBiophys Acta"},{"issue":"12","key":"10375_CR47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1875-5364(17)30015-8","volume":"14","author":"P Arumugam","year":"2016","unstructured":"Arumugam P, Subramanian R, Priyadharsini JV, Gopalswamy J (2016) Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9. Chin J Nat Med 14(12):904\u2013912. https:\/\/doi.org\/10.1016\/S1875-5364(17)30015-8","journal-title":"Chin J Nat Med"},{"key":"10375_CR48","doi-asserted-by":"publisher","first-page":"109022","DOI":"10.1016\/j.cbi.2020.109022","volume":"320","author":"M Zhang","year":"2020","unstructured":"Zhang M, Du H, Wang L, Yue Y, Zhang P, Huang Z, Lv W, Ma J, Shao Q, Ma M, Liang X, Yang T, Wang W, Zeng J, Chen G, Wang X, Fan J (2020) Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt\/\u03b2-catenin signaling pathway. Chem Biol Interact 320:109022. https:\/\/doi.org\/10.1016\/j.cbi.2020.109022","journal-title":"Chem Biol Interact"},{"issue":"11","key":"10375_CR49","doi-asserted-by":"publisher","first-page":"e56902","DOI":"10.15252\/embr.202356902","volume":"24","author":"X Yu","year":"2023","unstructured":"Yu X, He T, Tong Z, Liao L, Huang S, Fakhouri WD, Edwards DP, Xu J (2023) Molecular mechanisms of TWIST1-regulated transcription in EMT and cancer metastasis. EMBO Rep 24(11):e56902. https:\/\/doi.org\/10.15252\/embr.202356902","journal-title":"EMBO Rep"},{"issue":"23","key":"10375_CR50","doi-asserted-by":"publisher","first-page":"19580","DOI":"10.18632\/oncotarget.3973","volume":"6","author":"MA Khan","year":"2015","unstructured":"Khan MA, Tania M, Wei C, Mei Z, Fu S, Cheng J, Xu J, Fu J (2015) Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. Oncotarget 6(23):19580\u201319591. https:\/\/doi.org\/10.18632\/oncotarget.3973","journal-title":"Oncotarget"},{"issue":"12","key":"10375_CR51","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3390\/molecules22122105","volume":"22","author":"J Li","year":"2017","unstructured":"Li J, Khan MA, Wei C, Cheng J, Chen H, Yang L, Ijaz I, Fu J (2017) Thymoquinone inhibits the migration and invasive characteristics of cervical cancer cells SiHa and CaSki in vitro by targeting epithelial to mesenchymal transition associated transcription factors Twist1 and Zeb1. Molecules 22(12):2105. https:\/\/doi.org\/10.3390\/molecules22122105","journal-title":"Molecules"},{"issue":"11","key":"10375_CR52","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/tox.22822","volume":"34","author":"YF Liou","year":"2019","unstructured":"Liou YF, Chen PN, Chu SC et al (2019) Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species-induced apoptosis and reduces cell stemness. Environ Toxicol 34(11):1208\u20131220. https:\/\/doi.org\/10.1002\/tox.22822","journal-title":"Environ Toxicol"},{"issue":"5","key":"10375_CR53","doi-asserted-by":"publisher","first-page":"686","DOI":"10.7150\/ijms.32763","volume":"16","author":"YF Liou","year":"2019","unstructured":"Liou YF, Hsieh YS, Hung TW, Chen PN, Chang YZ, Kao SH, Lin SW, Chang HR (2019) Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K\/Srcsignaling. Int J Med Sci 16(5):686\u2013695. https:\/\/doi.org\/10.7150\/ijms.32763","journal-title":"Int J Med Sci"},{"issue":"1","key":"10375_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10375_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1871529X18666180212114816","volume":"18","author":"H Shaterzadeh-Yazdi","year":"2018","unstructured":"Shaterzadeh-Yazdi H, Noorbakhsh MF, Hayati F, Samarghandian S, Farkhondeh T (2018) Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovasc Hematol Disord Drug Targets 18(1):52\u201360. https:\/\/doi.org\/10.2174\/1871529X18666180212114816","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"5","key":"10375_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1477-2574.2009.00059.x","volume":"11","author":"N Chehl","year":"2009","unstructured":"Chehl N, Chipitsyna G, Gong Q, Yeo CJ, Arafat HA (2009) Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11(5):373\u2013381. https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00059.x","journal-title":"HPB (Oxford)"},{"key":"10375_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"10375_CR58","doi-asserted-by":"publisher","first-page":"42995","DOI":"10.1038\/srep42995","volume":"7","author":"MJ Hossen","year":"2017","unstructured":"Hossen MJ, Yang WS, Kim D, Aravinthan A, Kim JH, Cho JY (2017) Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities. Sci Rep 7:42995. https:\/\/doi.org\/10.1038\/srep42995","journal-title":"Sci Rep"},{"issue":"12","key":"10375_CR59","first-page":"950","volume":"17","author":"M Khader","year":"2014","unstructured":"Khader M, Eckl PM (2014) Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci 17(12):950\u2013957","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"10375_CR60","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.3390\/ijms24119647","volume":"24","author":"JL Wautier","year":"2023","unstructured":"Wautier JL, Wautier MP (2023) Pro- and anti-inflammatory prostaglandins and cytokines in humans: a mini review. Int J Mol Sci 24(11):9647. https:\/\/doi.org\/10.3390\/ijms24119647","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10375_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/1319-3767.41725","volume":"14","author":"M Tariq","year":"2008","unstructured":"Tariq M (2008) Nigella sativa seeds: folklore treatment in modern day medicine. Saudi J Gastroenterol 14(3):105\u2013106. https:\/\/doi.org\/10.4103\/1319-3767.41725","journal-title":"Saudi J Gastroenterol"},{"issue":"12","key":"10375_CR62","first-page":"929","volume":"17","author":"F Forouzanfar","year":"2014","unstructured":"Forouzanfar F, Bazzaz BS, Hosseinzadeh H (2014) Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci 17(12):929\u2013938","journal-title":"Iran J Basic Med Sci"},{"key":"10375_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.toxrep.2022.04.020","volume":"9","author":"JV Thomas","year":"2022","unstructured":"Thomas JV, Mohan ME, Prabhakaran P, Das SS, Maliakel B, Krishnakumar IM (2022) A phase I clinical trial to evaluate the safety of thymoquinone-rich black cumin oil (BlaQmax\u00ae) on healthy subjects: randomized, double-blinded, placebo-controlled prospective study. Toxicol Rep 9:999\u20131007. https:\/\/doi.org\/10.1016\/j.toxrep.2022.04.020","journal-title":"Toxicol Rep"},{"issue":"17","key":"10375_CR64","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.3390\/nu14173501","volume":"14","author":"E Khaikin","year":"2022","unstructured":"Khaikin E, Chrubasik-Hausmann S, Kaya S, Zimmermann BF (2022) Screening of thymoquinone content in commercial nigella sativa products to identify a promising and safe study medication. Nutrients 14(17):3501. https:\/\/doi.org\/10.3390\/nu14173501","journal-title":"Nutrients"},{"key":"10375_CR65","first-page":"133","volume":"10","author":"M Amini","year":"2011","unstructured":"Amini M, Huseini HF, Mohtashami R, Ghamarchehre MA (2011) Hypolipidemic effects of Nigella sativa L. seeds oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. J Med Plants 10:133\u2013138","journal-title":"J Med Plants"},{"issue":"12","key":"10375_CR66","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/ptr.4944","volume":"27","author":"H Fallah Huseini","year":"2013","unstructured":"Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, Fallah Huseini A (2013) Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res 27(12):1849\u20131853. https:\/\/doi.org\/10.1002\/ptr.4944","journal-title":"Phytother Res"},{"issue":"2","key":"10375_CR67","first-page":"25","volume":"20","author":"A Al-Ali","year":"2008","unstructured":"Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA (2008) Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad 20(2):25\u201327","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"1","key":"10375_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1078\/0944-7113-00084","volume":"9","author":"A Zaoui","year":"2002","unstructured":"Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M (2002) Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 9(1):69\u201374. https:\/\/doi.org\/10.1078\/0944-7113-00084","journal-title":"Phytomedicine"},{"key":"10375_CR69","first-page":"811","volume":"11","author":"K Ramalingam","year":"2021","unstructured":"Ramalingam K, Kuttan R, Sivadasan SD, Ittiyavirah S, Madhavamenon KI (2021) Safety assessment of a thymoquinone-rich black cumin oil (BlaQmax\u00ae): acute and sub-chronic toxicity studies. J Nutr Food Sci 11:811","journal-title":"J Nutr Food Sci"},{"key":"10375_CR70","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.2147\/IJN.S114205","volume":"11","author":"YS Ong","year":"2016","unstructured":"Ong YS, Saiful Yazan L, Ng WK, Noordin MM, Sapuan S, Foo JB, Tor YS (2016) Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB\/c mice. Int J Nanomedicine 11:5905\u20135915. https:\/\/doi.org\/10.2147\/IJN.S114205","journal-title":"Int J Nanomedicine"},{"key":"10375_CR71","doi-asserted-by":"publisher","first-page":"110070","DOI":"10.1016\/j.cbi.2022.110070","volume":"365","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang Z, Wang X, Lv X, Yin H, Jiang L, Xia Y, Li W, Li W, Liu Y (2022) Potential food-drug interaction risk of thymoquinone with warfarin. Chem Biol Interact 365:110070. https:\/\/doi.org\/10.1016\/j.cbi.2022.110070","journal-title":"Chem Biol Interact"},{"key":"10375_CR72","doi-asserted-by":"publisher","first-page":"109801","DOI":"10.1016\/j.cbi.2022.109801","volume":"353","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang X, Wang Z, Lv X, Yin H, Li W, Li W, Jiang L, Liu Y (2022) Potential herb-drug interaction risk of thymoquinone and phenytoin. Chem Biol Interact 353:109801. https:\/\/doi.org\/10.1016\/j.cbi.2022.109801","journal-title":"Chem Biol Interact"},{"issue":"5","key":"10375_CR73","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.drudis.2018.01.043","volume":"23","author":"F Ballout","year":"2018","unstructured":"Ballout F, Habli Z, Rahal ON, Fatfat M, Gali-Muhtasib H (2018) Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discov Today 23(5):1089\u20131098. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.043","journal-title":"Drug Discov Today"},{"issue":"19","key":"10375_CR74","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.3390\/molecules27196744","volume":"27","author":"MH Shariare","year":"2022","unstructured":"Shariare MH, Khan MA, Al-Masum A, Khan JH, Uddin J, Kazi M (2022) Development of stable liposomal drug delivery system of thymoquinone and its in vitro anticancer studies using breast cancer and cervical cancer cell lines. Molecules 27(19):6744. https:\/\/doi.org\/10.3390\/molecules27196744","journal-title":"Molecules"},{"issue":"18","key":"10375_CR75","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.3390\/polym14183705","volume":"14","author":"SS Imam","year":"2022","unstructured":"Imam SS, Gilani SJ, Bin Jumah MN, Rizwanullah M, Zafar A, Ahmed MM, Alshehri S (2022) Harnessing lipid polymer hybrid nanoparticles for enhanced oral bioavailability of thymoquinone: in vitro and in vivo assessments. Polymers (Basel) 14(18):3705. https:\/\/doi.org\/10.3390\/polym14183705","journal-title":"Polymers (Basel)"},{"issue":"1","key":"10375_CR76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/coatings11010006","volume":"11","author":"S Alshehri","year":"2021","unstructured":"Alshehri S, Imam SS, Rizwanullah M, Fakhri KU, Rizvi MMA, Mahdi W, Kazi M (2021) Effect of chitosan coating on PLGA nanoparticles for oral delivery of thymoquinone: in vitro, ex vivo, and cancer cell line assessments. Coatings 11(1):6. https:\/\/doi.org\/10.3390\/coatings11010006","journal-title":"Coatings"},{"issue":"3","key":"10375_CR77","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1871520620666200807221047","volume":"21","author":"TD \u00dcnal","year":"2021","unstructured":"\u00dcnal TD, Hamurcu Z, Deliba\u015f\u0131 N et al (2021) Thymoquinone inhibits proliferation and migration of MDA-MB-231 triple negative breast cancer cells by suppressing autophagy, beclin-1 and LC3. Anticancer Agents Med Chem 21(3):355\u2013364. https:\/\/doi.org\/10.2174\/1871520620666200807221047","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"10375_CR78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10549-018-4847-2","volume":"171","author":"N Kabil","year":"2018","unstructured":"Kabil N, Bayraktar R, Kahraman N et al (2018) Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res Treat 171(3):593\u2013605. https:\/\/doi.org\/10.1007\/s10549-018-4847-2","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10375_CR79","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/tox.23664","volume":"38","author":"A Mai","year":"2023","unstructured":"Mai A, Ye SW, Tu JY et al (2023) Thymoquinone induces apoptosis in temozolomide-resistant glioblastoma cells via the p38 mitogen-activated protein kinase signaling pathway. Environ Toxicol 38(1):90\u2013100. https:\/\/doi.org\/10.1002\/tox.23664","journal-title":"Environ Toxicol"},{"issue":"5","key":"10375_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4149\/BLL_2018_059","volume":"119","author":"G Kus","year":"2018","unstructured":"Kus G, Ozkurt M, Kabadere S, Erkasap N, Goger G, Demirci F (2018) Antiproliferative and antiapoptotic effect of thymoquinone on cancer cells in vitro. Bratisl Lek Listy 119(5):312\u2013316. https:\/\/doi.org\/10.4149\/BLL_2018_059","journal-title":"Bratisl Lek Listy"},{"key":"10375_CR81","doi-asserted-by":"publisher","first-page":"112604","DOI":"10.1016\/j.fct.2021.112604","volume":"157","author":"PK Raut","year":"2021","unstructured":"Raut PK, Lee HS, Joo SH, Chun KS (2021) Thymoquinone induces oxidative stress-mediated apoptosis through downregulation of Jak2\/STAT3 signaling pathway in human melanoma cells. Food Chem Toxicol 157:112604. https:\/\/doi.org\/10.1016\/j.fct.2021.112604","journal-title":"Food Chem Toxicol"},{"key":"10375_CR82","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.wneu.2018.02.136","volume":"114","author":"MA Hatiboglu","year":"2018","unstructured":"Hatiboglu MA, Kocyigit A, Guler EM et al (2018) Thymoquinone induces apoptosis in B16\u2013F10 melanoma cell through inhibition of p-STAT3 and inhibits tumor growth in a murine intracerebral melanoma model. World Neurosurg 114:e182\u2013e190. https:\/\/doi.org\/10.1016\/j.wneu.2018.02.136","journal-title":"World Neurosurg"},{"key":"10375_CR83","doi-asserted-by":"publisher","first-page":"111253","DOI":"10.1016\/j.fct.2020.111253","volume":"139","author":"IG Chae","year":"2020","unstructured":"Chae IG, Song NY, Kim DH, Lee MY, Park JM, Chun KS (2020) Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2\/STAT3 through pro-oxidant effect. Food Chem Toxicol 139:111253. https:\/\/doi.org\/10.1016\/j.fct.2020.111253","journal-title":"Food Chem Toxicol"},{"issue":"12","key":"10375_CR84","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1111\/cas.13808","volume":"109","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Fan Y, Huang S et al (2018) Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK\/mTOR signaling pathway. Cancer Sci 109(12):3865\u20133873. https:\/\/doi.org\/10.1111\/cas.13808","journal-title":"Cancer Sci"},{"key":"10375_CR85","doi-asserted-by":"publisher","first-page":"108799","DOI":"10.1016\/j.cbi.2019.108799","volume":"312","author":"JE Park","year":"2019","unstructured":"Park JE, Kim DH, Ha E et al (2019) Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3. Chem Biol Interact 312:108799. https:\/\/doi.org\/10.1016\/j.cbi.2019.108799","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10375_CR86","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.4103\/jcrt.jcrt_883_23","volume":"20","author":"M Khan","year":"2024","unstructured":"Khan M, Lam SK, Yan S et al (2024) The anti-neoplastic impact of thymoquinone from Nigella sativa on small cell lung cancer: In vitro and in vivo investigations. J Cancer Res Ther 20(4):1224\u20131231. https:\/\/doi.org\/10.4103\/jcrt.jcrt_883_23","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"10375_CR87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/plants13010035","volume":"13","author":"SK Haif","year":"2023","unstructured":"Haif SK, Al Kury LT, Talib WH (2023) Combination of thymoquinone and intermittent fasting as a treatment for breast cancer implanted in mice. Plants (Basel) 13(1):35. https:\/\/doi.org\/10.3390\/plants13010035","journal-title":"Plants (Basel)"},{"issue":"1","key":"10375_CR88","doi-asserted-by":"publisher","first-page":"e23230","DOI":"10.1002\/jbt.23230","volume":"37","author":"G Nithya","year":"2023","unstructured":"Nithya G, Santhanasabapathy R, Vanitha MK, Anandakumar P, Sakthisekaran D (2023) Antioxidant, antiproliferative, and apoptotic activity of thymoquinone against benzo(a)pyrene-induced experimental lung cancer. J Biochem Mol Toxicol 37(1):e23230. https:\/\/doi.org\/10.1002\/jbt.23230","journal-title":"J Biochem Mol Toxicol"},{"key":"10375_CR89","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.2147\/JIR.S358632","volume":"15","author":"A Khan","year":"2022","unstructured":"Khan A, Alsahli MA, Aljasir MA et al (2022) Experimental and theoretical insights on chemopreventive effect of the liposomal thymoquinone against Benzo[a]pyrene-induced lung cancer in swiss albino mice. J Inflamm Res 15:2263\u20132280. https:\/\/doi.org\/10.2147\/JIR.S358632","journal-title":"J Inflamm Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10375-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:17Z","timestamp":1766853137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10375"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10375-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"It\u2019s a review article. So, no ethical approval and no consent from participants is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All the authors read and approved the final version of the manuscript. The authors do not want open access to the manuscript. Therefore, we assure you that this manuscript was not send for publication in any other journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"268"}}